Vol. 1 No. 9 (2026)

Published September 3, 2026
GCMHS

Articles

Azizbek Melikuziev, Giyosiddin Askaraliev, Azizbek Baratov, Umarkhon Mamatkhonov (Author)
181-201
TYPE 2 DIABETES MELLITUS: FROM HYPERGLYCEMIA-INDUCED BIOCHEMICAL ALTERATIONS TO RENAL HISTOPATHOLOGY
pdf
Ешимбетова Г. З., Шарипова Н. М., Мусаходжаева Д. А., Шаикрамова Н. Х, Азизова З. Ш., Келдиерова Р. Б. (Author)
202-206
КЛИНИКО-ГОРМОНАЛЬНЫЕ ОСОБЕННОСТИ ГИПЕРПЛАЗИИ ЭНДОМЕТРИЯ, АССОЦИИРОВАННОЙ С МЕТАБОЛИЧЕСКИМИ НАРУШЕНИЯМИ
pdf
Юсупова Дилдора Зухриддиновна (Author)
1-4
ПЕРСОНАЛИЗИРОВАННЫЙ ПОДХОД К ПРОФИЛАКТИКЕ И ЛЕЧЕНИЮ ПОСЛЕОПЕРАЦИОННЫХ РУБЦОВ ЛИЦА
pdf
M. Rustamova (Author)
5-12
SINGLE-CELL RNA SEQUENCING IN PRECISION MEDICINE: FROM CELLULAR HETEROGENEITY TO CLINICAL APPLICATION
pdf
M. Rustamova (Author)
13-20
POLYGENIC RISK SCORES FOR COMPLEX DISEASE PREDICTION: CLINICAL UTILITY AND IMPLEMENTATION CHALLENGES
pdf
M. Rustamova (Author)
21-28
MITOCHONDRIAL DNA HETEROPLASMY IN DISEASE: DIAGNOSTIC CHALLENGES AND EMERGING THERAPEUTIC STRATEGIES
pdf
M. Rustamova (Author)
29-36
CRISPR-CAS9 GENE EDITING THERAPEUTICS: FROM FIRST APPROVAL TO EXPANDING CLINICAL PIPELINE
pdf
M. Rustamova (Author)
37-44
WHOLE GENOME SEQUENCING FOR THE DIAGNOSIS OF RARE GENETIC DISORDERS: DIAGNOSTIC YIELD AND CLINICAL VALUE
pdf
M. Rustamova (Author)
45-52
DNA METHYLATION AS A LIQUID BIOPSY BIOMARKER FOR EARLY CANCER DETECTION
pdf
M. Rustamova (Author)
53-60
CYP2D6 PHARMACOGENETICS AND PHENOCONVERSION IN PERSONALIZED PRESCRIBING
pdf
M. Rustamova (Author)
61-68
NON-CODING RNAs AS EMERGING BIOMARKERS AND THERAPEUTIC TARGETS IN CANCER AND INFLAMMATORY DISEASE
pdf
З. Е. Умарназарова, М. А. Мухитдинова (Author)
69-70
ВЛИЯНИЕ ВИДА ВСКАРМЛИВАНИЯ НА ТЕЧЕНИЕ СМЕШАННОЙ ФОРМЫ МУКОВИСЦИДОЗА У ДЕТЕЙ
pdf
Turaeva S. N., Nurova A. A., Ilyasov A. B. (Author)
71-77
PRE-INTERPRETATION QUALITY FAILURES IN INTRAPARTUM CARDIOTOCOGRAPHY: SIGNAL ADEQUACY AND MISSING UTERINE ACTIVITY IN A TERTIARY CENTRE
pdf
Khodjasheva Saidakhon, Ropijonova Farzona, Maksetbaeva Nargiza (Author)
78-79
PREVALENCE OF DIATHESIS AND RISK FACTORS
pdf
Fazliddin Arzikulov (Author)
80-87
CRISPR-CAS9 GENE EDITING THERAPY: FROM BENCH TO CLINICAL APPROVAL
pdf
Fazliddin Arzikulov (Author)
88-95
MRNA VACCINE TECHNOLOGY IN CANCER IMMUNOTHERAPY
pdf
Fazliddin Arzikulov (Author)
96-104
CAR-T CELL IMMUNOTHERAPY: CURRENT CHALLENGES AND CONVERGENCE WITH mRNA TECHNOLOGY
pdf
Fazliddin Arzikulov (Author)
105-112
WEARABLE BIOSENSORS FOR CONTINUOUS HEALTH MONITORING
pdf
Fazliddin Arzikulov (Author)
113-120
3D BIOPRINTING FOR ORGAN AND TISSUE REGENERATION
pdf
Fazliddin Arzikulov (Author)
121-128
STEM CELL-LADEN HYDROGELS FOR BONE AND CARTILAGE TISSUE ENGINEERING
pdf
Fazliddin Arzikulov (Author)
129-136
ANTIBODY-CONJUGATED NANOPARTICLES FOR TARGETED CANCER DRUG DELIVERY
pdf
Fazliddin Arzikulov (Author)
137-144
ORGAN-ON-A-CHIP TECHNOLOGY INTEGRATED WITH BIOPRINTED ORGANOIDS
pdf
Fazliddin Arzikulov (Author)
145-152
ANTIBODY-DRUG CONJUGATES: EXPANDING CLINICAL LANDSCAPE AND COMBINATION STRATEGIES
pdf
Fazliddin Arzikulov (Author)
153-160
GUT MICROBIOTA-BASED NANOTHERAPIES FOR CANCER TREATMENT
pdf
Xayitmurodova Xanifa Shuxrat qizi (Author)
161-167
IMPROVING STRATEGIC MANAGEMENT MECHANISMS FOR LOGISTICS ACTIVITIES IN INDUSTRIAL ENTERPRISES
pdf
Kayumova D. T., Fayzullakhodjaeva A. O., Rakhimova Sh.M. (Author)
168-171
GUT MICROBIOME IN NAUSEA, VOMITING, AND HYPEREMESIS GRAVIDARUM DURING PREGNANCY: CURRENT EVIDENCE
pdf
Кулбоева Н. Ш., Умарназарова З. Э. (Author)
172-180
ФУНКЦИОНАЛЬНОЕ СОСТОЯНИЕ СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ У ДЕТЕЙ С ЯЗВЕННЫМ КОЛИТОМ В ЗАВИСИМОСТИ ОТ АКТИВНОСТИ ЗАБОЛЕВАНИЯ
pdf